Literature DB >> 24904106

CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence.

Fiorina Giona1, Luciana Teofili2, Sara Capodimonti2, Marica Laurino1, Maurizio Martini3, Deborah Marzella1, Giovanna Palumbo1, Daniela Diverio1, Robin Foà1, Luigi Maria Larocca3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24904106     DOI： 10.1182/blood-2014-04-572040

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Mutational profile of childhood myeloproliferative neoplasms.

Authors:  A Karow; R Nienhold; P Lundberg; E Peroni; M C Putti; M L Randi; R C Skoda
Journal:  Leukemia       Date:  2015-07-30       Impact factor: 11.528

2.  Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia.

Authors:  Fiorina Giona; Isabella Massimi; Maria Luisa Guarino; Michelina Santopietro; Marica Laurino; Flavia Temperilli; Giovanna Palumbo; Robin Foà; Fabio Maria Pulcinelli
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

3.  JAK2, MPL, and CALR mutations in children with essential thrombocythemia.

Authors:  Yuko Sekiya; Yusuke Okuno; Hideki Muramatsu; Olfat Ismael; Nozomu Kawashima; Atsushi Narita; Xinan Wang; Yinyan Xu; Asahito Hama; Hiroyuki Fujisaki; Toshihiko Imamura; Daiichiro Hasegawa; Yoshiyuki Kosaka; Shosuke Sunami; Yoshitoshi Ohtsuka; Shouichi Ohga; Yoshiyuki Takahashi; Seiji Kojima; Akira Shimada
Journal:  Int J Hematol       Date:  2016-05-21       Impact factor: 2.490

Review 4.  Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender.

Authors:  Jeffrey Patterson-Fortin; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

5.  Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

Authors:  F Palandri; R Latagliata; N Polverelli; A Tieghi; M Crugnola; B Martino; M Perricone; M Breccia; E Ottaviani; N Testoni; F Merli; F Aversa; G Alimena; M Cavo; G Martinelli; L Catani; M Baccarani; N Vianelli
Journal:  Leukemia       Date:  2015-03-24       Impact factor: 11.528

6.  Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children.

Authors:  R Fu; D Liu; Z Cao; S Zhu; H Li; H Su; L Zhang; F Xue; X Liu; X Zhang; T Cheng; R Yang; L Zhang
Journal:  Leukemia       Date:  2015-06-29       Impact factor: 11.528

7.  Three Novel Calreticulin Mutations in Two Turkish Patients.

Authors:  Veysel Sabri Hançer; Hüseyin Tokgöz; Serkan Güvenç; Ümran Çalışkan; Murat Büyükdoğan
Journal:  Turk J Haematol       Date:  2017-07-27       Impact factor: 1.831

8.  Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.

Authors:  Jean-Christophe Ianotto; Natalia Curto-Garcia; Marie Lauermanova; Deepti Radia; Jean-Jacques Kiladjian; Claire N Harrison
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.